Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Beth Israel Deaconess Medical Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Massachusetts General Hospital
University of California, San Francisco
Northwestern University
University of Rochester